Shenzhen Bioeasy (China) Top Management
300942 Stock | 9.88 0.74 6.97% |
Shenzhen Bioeasy employs about 389 people. The company is managed by 7 executives with a total tenure of roughly 908 years, averaging almost 129.0 years of service per executive, having 55.57 employees per reported executive. Analysis of Shenzhen Bioeasy's management performance can provide insight into the company performance.
Zhaoli Xiao Director Deputy Director |
Wentian Li Executive Secretary GM |
Shenzhen |
Shenzhen Bioeasy Management Team Effectiveness
The company has return on total asset (ROA) of (0.0157) % which means that it has lost $0.0157 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0919) %, meaning that it generated substantial loss on money invested by shareholders. Shenzhen Bioeasy's management efficiency ratios could be used to measure how well Shenzhen Bioeasy manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Other Assets is expected to grow to about 50.3 M, whereas Total Assets are forecasted to decline to about 869.7 M.The current year's Net Income Applicable To Common Shares is expected to grow to about 285.6 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 318.2 M.
Shenzhen Bioeasy Workforce Comparison
Shenzhen Bioeasy Biotechnology is number one stock in number of employees category among its peers. The total workforce of Health Care industry is presently estimated at about 75,904. Shenzhen Bioeasy maintains roughly 389 in number of employees contributing less than 1% to equities under Health Care industry.
The company has Profit Margin (PM) of (0.33) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.02 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.02. Shenzhen Bioeasy Bio Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Shenzhen Bioeasy Bio Price Series Summation is a cross summation of Shenzhen Bioeasy price series and its benchmark/peer.
Shenzhen Bioeasy Notable Stakeholders
A Shenzhen Bioeasy stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Shenzhen Bioeasy often face trade-offs trying to please all of them. Shenzhen Bioeasy's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Shenzhen Bioeasy's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Zhaoli Xiao | Deputy Director | Profile | |
Zhiying Chen | Deputy Director | Profile | |
Wenhao Yan | Deputy Director | Profile | |
Hehua Lu | GM Director | Profile | |
Hui Fu | Deputy Director | Profile | |
Wentian Li | Secretary GM | Profile | |
Yaqin Chi | NonIndependent Mang | Profile |
About Shenzhen Bioeasy Management Performance
The success or failure of an entity such as Shenzhen Bioeasy Bio often depends on how effective the management is. Shenzhen Bioeasy management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Shenzhen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Shenzhen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Shenzhen Bioeasy is entity of China. It is traded as Stock on SHE exchange.
Please note, the presentation of Shenzhen Bioeasy's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Shenzhen Bioeasy's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Shenzhen Bioeasy's management manipulating its earnings.
Shenzhen Bioeasy Workforce Analysis
Traditionally, organizations such as Shenzhen Bioeasy use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Shenzhen Bioeasy within its industry.Shenzhen Bioeasy Manpower Efficiency
Return on Shenzhen Bioeasy Manpower
Revenue Per Employee | 653.2K | |
Revenue Per Executive | 36.3M | |
Net Loss Per Employee | 475.3K | |
Net Loss Per Executive | 26.4M | |
Working Capital Per Employee | 1.5M | |
Working Capital Per Executive | 85.8M |
Complementary Tools for Shenzhen Stock analysis
When running Shenzhen Bioeasy's price analysis, check to measure Shenzhen Bioeasy's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shenzhen Bioeasy is operating at the current time. Most of Shenzhen Bioeasy's value examination focuses on studying past and present price action to predict the probability of Shenzhen Bioeasy's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shenzhen Bioeasy's price. Additionally, you may evaluate how the addition of Shenzhen Bioeasy to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |